SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-093202
Filing Date
2024-04-11
Accepted
2024-04-11 16:07:58
Documents
8

Document Format Files

Seq Description Document Type Size
1 DEFA14A d130511ddefa14a.htm DEFA14A 23805
2 GRAPHIC g130511g12e58.jpg GRAPHIC 2791
3 GRAPHIC g130511g15u48.jpg GRAPHIC 1271
4 GRAPHIC g130511g29k33.jpg GRAPHIC 15691
5 GRAPHIC g130511g39x73.jpg GRAPHIC 2440
6 GRAPHIC g130511g52h15.jpg GRAPHIC 9486
7 GRAPHIC g130511g91j24.jpg GRAPHIC 1500
8 GRAPHIC g130511g92l81.jpg GRAPHIC 1274
  Complete submission text file 0001193125-24-093202.txt   73323
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38692 | Film No.: 24838572
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)